Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tokiwa

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Scientific Reports|February 8, 2017
Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector arrayM Toi, Y Asao, Y Matsumoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2024
A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B)H Sakai, J Tsurutani, Y Ozaki, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Scientific Reports|February 8, 2017
Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector arrayM Toi, Y Asao, Y Matsumoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2024
A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B)H Sakai, J Tsurutani, Y Ozaki, et al.
Pageof 3